Evidence map›Paper›PMID 38061853›Full record

ArticleBMJ case reports2023

Systematic approach to diagnosing suspected Creutzfeldt-Jakob disease.

Matthew M Rode, Christopher Itoh, Santiago Martinez-Sosa, Blake A Ebner, Bryce K Chang, Eoin P Flanagan, Marcus V Pinto

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 68% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Matthew M RodeMayo Clinic Alix School of Medicine, Rochester, Minnesota, USA.ORCID http://orcid.org/0000-0002-3190-2627
Christopher ItohDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Santiago Martinez-SosaDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Blake A EbnerDepartment of Pathology, Mayo Clinic, Rochester, MN, USA.
Bryce K ChangDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Eoin P FlanaganDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Marcus V PintoDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA pinto.marcus@mayo.edu.
Mayo Clinic · USMayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evaluation of rapidly progressive dementia (RPD) is usually challenging. In most cases, patients progress to dementia in weeks to months, and the differential diagnosis is broad. In this case, a woman in her 60s presented with a 1-month history of episodic vertigo, cognitive decline, ataxia and myoclonus. Cerebrospinal fluid total tau was markedly elevated, which was helpful in establishing the diagnosis and discussing prognosis/end-of-life measures with the patient's family. This case summarises a stepwise diagnostic approach for patients with RPD and highlights recent literature on biomarkers of Creutzfeldt-Jakob disease and autoimmune encephalitis.

Indexed as

Cognitive DysfunctionCreutzfeldt-Jakob SyndromeEncephalitisMyoclonusBiomarkersDiagnosis, DifferentialFemaleHumansBiomarkersBrain stem/cerebellumMovement disorders (other than Parkinson's)NeuroimagingVariant Creutzfeldt-Jakob disease

Identifiers

PMID38061853
PMCPMC10711900
OpenAlexW4389462898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.